Gavin Giovannoni holds the Chair of Neurology, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University London and the Department of Neurology, Barts Health NHS Trust in November. Gavin did his undergraduate medical training at the University of the Witwatersrand, South Africa. His clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. He is particularly interested in clinical issues related to optimising MS disease-modifying therapies. His current research is focused on the Epstein Barr virus as a possible cause of multiple sclerosis, defining the “multiple sclerosis endophenotype”, multiple sclerosis-related neurodegeneration or smouldering MS, multiple sclerosis biomarker discovery, multiple sclerosis clinical outcomes and in the past immune tolerance strategies. His team focus on translational research and, therefore, has an active clinical trial programme. Gavin has developed and validated several innovations to communicate complex information to people with MS and their families (see ClinicSpeak, MS Brain Health, Digesting Science and MS-Selfie).
